2
RESEARCH METHODOLOGY
38
5
MARKET OVERVIEW
Explore the booming respiratory diagnostics market driven by tech advancements and growing health awareness.
59
5.2.1.1
INCREASING INCIDENCE OF RESPIRATORY DISORDERS
5.2.1.2
EXPANDING GERIATRIC POPULATION AND RISE IN SEDENTARY LIFESTYLES
5.2.1.3
GROWING AWARENESS ABOUT RESPIRATORY HEALTH
5.2.1.4
ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES
5.2.2.1
HIGH COST OF DIAGNOSTIC TESTS
5.2.2.2
LIMITED REIMBURSEMENTS
5.2.2.3
SHORTAGE OF SKILLED PROFESSIONALS
5.2.3.1
HIGH GROWTH POTENTIAL OF EMERGING ECONOMIES
5.2.3.2
INCREASING DEMAND FOR POC TESTING
5.2.3.3
GROWING AWARENESS ABOUT UNTREATED OSA
5.2.4.1
COMPLEXITIES ASSOCIATED WITH DIAGNOSIS OF VIRAL RESPIRATORY INFECTIONS
5.2.4.2
LIMITED ACCESS TO PERIPHERAL LUNG LESIONS IN BRONCHOSCOPY
5.3.1
POINT-OF-CARE TESTING
5.3.2
PERSONALIZED MEDICINE
5.4.1.1
HOME-BASED & PERSONAL DHTS
5.4.1.2
PFT TOOLS AND MOLECULAR & IMAGING DIAGNOSTICS
5.4.2
COMPLEMENTARY TECHNOLOGIES
5.4.2.1
AI-ENHANCED IMAGING
5.4.2.2
SEROLOGICAL & TELEHEALTH PLATFORMS
5.4.3
ADJACENT TECHNOLOGIES
5.4.3.1
RAPID RESPIRATORY DIAGNOSTIC TESTS
5.5
PORTER’S FIVE FORCES ANALYSIS
5.5.1
THREAT OF NEW ENTRANTS
5.5.2
THREAT OF SUBSTITUTES
5.5.3
BARGAINING POWER OF SUPPLIERS
5.5.4
BARGAINING POWER OF BUYERS
5.5.5
INTENSITY OF COMPETITIVE RIVALRY
5.6.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2
REGULATORY LANDSCAPE
5.6.2.5
MIDDLE EAST & AFRICA
5.7.1
KEY PATENTS GRANTED
5.8.1
IMPORT DATA FOR HS CODE 901819
5.8.2
EXPORT DATA FOR HS CODE 901819
5.9.1
AVERAGE SELLING PRICE OF RESPIRATORY DIAGNOSTIC PRODUCTS, BY KEY PLAYER (2024)
5.9.2
AVERAGE SELLING PRICE TREND OF RESPIRATORY DIAGNOSTIC PRODUCTS, BY REGION, 2021–2023
5.10
VALUE CHAIN ANALYSIS
5.11
KEY STAKEHOLDERS & BUYING CRITERIA
5.11.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2
KEY BUYING CRITERIA
5.12
KEY CONFERENCES & EVENTS, 2024–2025
5.13
UNMET NEEDS/END-USER EXPECTATIONS
5.14
ADJACENT MARKET ANALYSIS
5.17
SUPPLY CHAIN ANALYSIS
5.18
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.19
INVESTMENT & FUNDING SCENARIO
5.20
REIMBURSEMENT SCENARIO
5.21
IMPACT OF AI/GENERATIVE AI ON RESPIRATORY DIAGNOSTICS MARKET
6
RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
100
6.2
INSTRUMENTS & DEVICES
6.2.1
INTRODUCTION OF AUTOMATED & HIGH-THROUGHPUT INSTRUMENTS TO DRIVE MARKET
6.3.1
INCREASING DEMAND FOR RESPIRATORY DIAGNOSTIC TEST KITS TO PROPEL MARKET
6.4.1
INCREASING DEMAND FOR CONSISTENT UPGRADES AND SUPPORT SERVICES TO FUEL MARKET
7
RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 33 Data Tables
106
7.2.1
PULMONARY FUNCTION TESTS
7.2.1.3
OTHER PULMONARY FUNCTION TESTS
7.2.2
OBSTRUCTIVE SLEEP APNEA DIAGNOSTIC TESTS
7.2.2.1
LARGE PRESENCE OF UNTREATED POPULATION TO DRIVE MARKET
7.2.3
OTHER MECHANICAL TESTS
7.3.1.1
INTEGRATION OF AI INTO X-RAY DEVICES FOR ENHANCED IMAGING CAPABILITIES TO DRIVE MARKET
7.3.2
COMPUTED TOMOGRAPHY
7.3.2.1
RISING FOCUS ON OBTAINING HIGH-RESOLUTION CT IMAGES TO BOOST DEMAND
7.3.3
MAGNETIC RESONANCE IMAGING (MRI)
7.3.3.1
ABILITY TO PROVIDE DETAILED LUNG IMAGES WITHOUT RADIATION EXPOSURE TO DRIVE MARKET
7.3.4
POSITRON EMISSION TOMOGRAPHY (PET)
7.3.4.1
GROWING FOCUS ON DETECTION & MONITORING OF TREATMENT RESPONSE TO LUNG CANCER TO DRIVE MARKET
7.3.5
OTHER IMAGING TESTS
7.4
TRADITIONAL DIAGNOSTIC TESTS
7.4.1.1
RISING DEMAND FOR RAPID DISEASE DIAGNOSIS TO FUEL UPTAKE
7.4.2.1
ABILITY TO ACCURATELY MEASURE BIOMARKERS IN PNEUMONIA AND BRONCHITIS INFECTIONS TO BOOST DEMAND
7.4.3.1
INADEQUATE SENSITIVITY TOWARDS EMERGING VIRUSES TO RESTRAIN MARKET
7.5
MOLECULAR DIAGNOSTIC TESTS
7.5.1
POLYMERASE CHAIN REACTION (PCR)
7.5.1.1
DEVELOPMENT OF PORTABLE AND REAL-TIME PCR MACHINES TO DRIVE MARKET
7.5.2
NUCLEIC ACID AMPLIFICATION TEST (NAAT)
7.5.2.1
RAPID IDENTIFICATION OF VIRAL, BACTERIAL, AND FUNGAL INFECTIONS TO FUEL DEMAND
7.5.3
IN SITU HYBRIDIZATION (ISH)
7.5.3.1
UTILIZATION OF PROBES FOR PATHOGEN DETECTION TO SUPPORT MARKET GROWTH
7.5.4
DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS)
7.5.4.1
HIGH-THROUGHPUT CAPABILITIES FOR RAPID ANALYSIS OF GENETIC DATA TO PROPEL MARKET
7.5.5.1
DETECTION OF HEPATITIS C AND RESPIRATORY VIRUSES TO SUPPORT MARKET GROWTH
7.5.6
OTHER MOLECULAR DIAGNOSTIC TESTS
8
RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 11 Data Tables
141
8.2.1
FAVORABLE FUNDING INITIATIVES FOR TB TREATMENT TO DRIVE MARKET
8.3.1
INCREASING AIR POLLUTION AND GROWING USE OF TOBACCO-BASED PRODUCTS TO DRIVE MARKET
8.4.1
NON-SMALL-CELL LUNG CANCER (NSCLC)
8.4.1.1
RISING INVESTMENTS IN ADVANCED RADIOGRAPHIC TECHNOLOGIES TO FUEL MARKET
8.4.2
SMALL-CELL LUNG CANCER (SCLC)
8.4.2.1
GROWING EMPHASIS ON PRECISION TESTING TO DRIVE MARKET
8.5
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
8.5.1
ADVANCEMENTS IN SPIROMETRY AND PLETHYSMOGRAPHY FOR COPD DIAGNOSIS TO FUEL MARKET
8.6.1
RISING INCIDENCE OF RESPIRATORY INFECTIONS TO BOOST DEMAND
9
RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
154
9.2.1
DETECTION OF MULTIPLE PANELS OF VIRAL PATHOGENS TO PROPEL MARKET
9.3
ETIOLOGICAL DIAGNOSIS
9.3.1
IDENTIFICATION OF SPECIFIC CAUSE OF RESPIRATORY ILLNESSES TO FUEL MARKET
9.4.1
ASSESSMENT OF BIOMARKERS FOR DISEASE PROGRESSION TO SUPPORT MARKET GROWTH
10
RESPIRATORY DIAGNOSTICS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 5 Data Tables
160
10.2.1
GROWING ACCESSIBILITY TO ADVANCED EQUIPMENT TO FUEL MARKET
10.3
DIAGNOSTIC LABORATORIES
10.3.1
ABILITY TO PROVIDE AFFORDABLE TESTING PROCESSES WITH TIMELY RESULTS TO BOOST DEMAND
10.4
LONG-TERM CARE & SPECIALTY CENTERS
10.4.1
PROVISION OF SPECIALIZED & ADVANCED SERVICES TO PROPEL MARKET
10.5
ACADEMIC & RESEARCH INSTITUTES
10.5.1
FAVORABLE FUNDING INITIATIVES TO SUPPORT MARKET GROWTH
11
RESPIRATORY DIAGNOSTICS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 18 Countries | 320 Data Tables.
166
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2.1
GROWING ACCESSIBILITY TO TECHNOLOGICALLY ADVANCED PRODUCTS TO BOOST DEMAND
11.2.3.1
RISING INCIDENCE OF COPD TO DRIVE MARKET
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2.1
INCREASING PUBLIC HEALTHCARE EXPENDITURE TO FOSTER MARKET GROWTH
11.3.3.1
RISING ESTABLISHMENT OF HOSPITALS AND INCREASING NUMBER OF SURGICAL PROCEDURES TO FUEL MARKET
11.3.4.1
HIGH PREVALENCE OF SMOKING AND INCREASING DEMAND FOR RESPIRATORY DEVICES TO DRIVE MARKET
11.3.5.1
UNFAVORABLE AMENDMENTS TO HEALTHCARE POLICIES TO RESTRAIN MARKET
11.3.6.1
INCREASING DEMAND FOR HOME HEALTHCARE SERVICES TO SUPPORT MARKET GROWTH
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2.1
AVAILABILITY OF UNIVERSAL HEALTHCARE REIMBURSEMENT POLICY TO DRIVE MARKET
11.4.3.1
HIGH INCIDENCE OF VIRAL RESPIRATORY INFECTIONS TO PROPEL MARKET
11.4.4.1
EXPANSION OF LEADING MEDICAL DEVICE MANUFACTURERS AND LARGE TARGET PATIENT POPULATION TO DRIVE MARKET
11.4.5.1
HIGH PREVALENCE OF CHRONIC LUNG DISEASES TO BOOST DEMAND
11.4.6.1
EXPANDING GERIATRIC POPULATION AND RISING INCIDENCE OF CHRONIC RESPIRATORY CONDITIONS TO FUEL MARKET
11.4.7
REST OF ASIA PACIFIC
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2.1
FAVORABLE GOVERNMENT INITIATIVES FOR HEALTHCARE SECTOR IMPROVEMENT TO DRIVE MARKET
11.5.3.1
RISING PREVALENCE OF OBESITY & HYPERTENSION TO FUEL UPTAKE
11.5.4
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2.1
KINGDOM OF SAUDI ARABIA (KSA)
11.6.2.2
UNITED ARAB EMIRATES (UAE)
11.6.2.3
OTHER GCC COUNTRIES
11.6.3
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
Discover top strategies and emerging leaders shaping market dynamics and growth opportunities.
290
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021–DECEMBER 2024
12.3
REVENUE ANALYSIS, 2019–2023
12.4
MARKET SHARE ANALYSIS, 2023
12.4.1
RANKING OF KEY MARKET PLAYERS
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGION FOOTPRINT
12.5.5.3
PRODUCT & SERVICE FOOTPRINT
12.5.5.4
TEST TYPE FOOTPRINT
12.5.5.5
DISEASE TYPE FOOTPRINT
12.5.5.6
END-USER FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7
BRAND/PRODUCT COMPARISON
12.8
R&D EXPENDITURE OF KEY PLAYERS
12.9
COMPANY VALUATION & FINANCIAL METRICS
12.10
COMPETITIVE SCENARIO
12.10.1
PRODUCT & SERVICE LAUNCHES AND APPROVALS
12.10.4
OTHER DEVELOPMENTS
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
313
13.1.1
KONINKLIJKE PHILIPS N.V.
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS & SERVICES OFFERED
13.1.1.3
RECENT DEVELOPMENTS
13.1.2
BECTON, DICKINSON AND COMPANY
13.1.3
ABBOTT LABORATORIES
13.1.4
THERMO FISHER SCIENTIFIC INC.
13.1.5
GE HEALTHCARE TECHNOLOGIES, INC.
13.1.6
BIO-RAD LABORATORIES, INC.
13.1.10
NIHON KOHDEN CORPORATION
13.1.14
SIEMENS HEALTHINEERS AG
13.2.1
MGC DIAGNOSTICS CORPORATION
13.2.2
VISBY MEDICAL, INC.
13.2.3
BRIOTA TECHNOLOGIES PVT. LTD.
13.2.5
LÖWENSTEIN MEDICAL SE & CO. KG
13.2.7
NDD MEDICAL TECHNOLOGIES
13.2.8
COMPUMEDICS LIMITED
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3
CUSTOMIZATION OPTIONS
TABLE 1
RESPIRATORY DIAGNOSTICS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3
RESPIRATORY DIAGNOSTICS MARKET: STUDY ASSUMPTIONS
TABLE 4
RESPIRATORY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 5
AWARENESS INITIATIVES ON EFFECTS OF UNTREATED SLEEP APNEA
TABLE 6
RESPIRATORY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
US: CLASSIFICATION OF MEDICAL EQUIPMENT
TABLE 13
US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 14
CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 15
EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 16
CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 17
JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 18
RESPIRATORY DIAGNOSTICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022−2024
TABLE 19
IMPORT DATA FOR HS CODE 901819, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 20
EXPORT DATA FOR HS CODE 901819, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 21
AVERAGE SELLING PRICE TREND OF RESPIRATORY DIAGNOSTIC PRODUCTS, BY REGION, 2021–2023 (USD)
TABLE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY DIAGNOSTIC DEVICES
TABLE 23
KEY BUYING CRITERIA FOR RESPIRATORY DIAGNOSTIC DEVICES
TABLE 24
RESPIRATORY DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2024−2025
TABLE 25
RESPIRATORY DIAGNOSTICS MARKET: ROLE IN ECOSYSTEM
TABLE 26
CASE STUDY 1: ACUPEBBLE SA100 – TRANSFORMING SLEEP APNEA DIAGNOSIS
TABLE 27
CASE STUDY 2: REMOTE MONITORING SOLUTION FOR COVID-19 PATIENTS IN INDONESIA
TABLE 28
CASE STUDY 3: EFFECTIVE MANAGEMENT OF A 71-YEAR-OLD COPD PATIENT WITH ACUTE EXACERBATIONS
TABLE 29
RESPIRATORY DIAGNOSTICS MARKET: REIMBURSEMENT SCENARIO
TABLE 30
RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 31
RESPIRATORY DIAGNOSTICS MARKET FOR INSTRUMENTS & DEVICES, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 32
RESPIRATORY DIAGNOSTICS MARKET FOR ASSAYS & REAGENTS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 33
RESPIRATORY DIAGNOSTICS MARKET FOR SERVICES & SOFTWARE, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 34
RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 35
RESPIRATORY DIAGNOSTICS MARKET FOR MECHANICAL TESTS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 36
RESPIRATORY DIAGNOSTICS MARKET FOR MECHANICAL TESTS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 37
RESPIRATORY DIAGNOSTICS MARKET FOR PULMONARY FUNCTION TESTS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 38
RESPIRATORY DIAGNOSTICS MARKET FOR PULMONARY FUNCTION TESTS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 39
SPIROMETRY TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 40
SPIROMETRY TESTS MARKET, BY REGION, 2022–2030 (THOUSAND UNITS)
TABLE 41
PEAK FLOW TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 42
PEAK FLOW TESTS MARKET, BY REGION, 2022–2030 (THOUSAND UNITS)
TABLE 43
OTHER PULMONARY TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 44
OTHER PULMONARY TESTS MARKET, BY REGION, 2022–2030 (THOUSAND UNITS)
TABLE 45
OBSTRUCTIVE SLEEP APNEA DIAGNOSTIC TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 46
OTHER MECHANICAL TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 47
RESPIRATORY DIAGNOSTICS MARKET FOR IMAGING TESTS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 48
RESPIRATORY DIAGNOSTICS MARKET FOR IMAGING TESTS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 49
X-RAY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 50
COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 51
MAGNETIC RESONANCE IMAGING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 52
POSITRON EMISSION TOMOGRAPHY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 53
OTHER IMAGING TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 54
RESPIRATORY DIAGNOSTICS MARKET FOR TRADITIONAL DIAGNOSTIC TESTS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 55
RESPIRATORY DIAGNOSTICS MARKET FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 56
IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 57
BIOCHEMICAL TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 58
MICROSCOPY MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 59
RESPIRATORY DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTIC TESTS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 60
RESPIRATORY DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 61
PCR MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 62
NUCLEIC ACID AMPLIFICATION TEST MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 63
IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 64
DNA SEQUENCING & NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 65
MICROARRAYS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 66
OTHER MOLECULAR DIAGNOSTIC TESTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 67
RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 68
RESPIRATORY DIAGNOSTICS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 69
RESPIRATORY DIAGNOSTICS MARKET FOR ASTHMA, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 70
RESPIRATORY DIAGNOSTICS MARKET FOR LUNG CANCER, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 71
RESPIRATORY DIAGNOSTICS MARKET FOR LUNG CANCER, BY TYPE, 2022–2030 (USD MILLION)
TABLE 72
NON-SMALL-CELL LUNG CANCER MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 73
SMALL-CELL LUNG CANCER MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 74
OTHER LUNG CANCERS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 75
RESPIRATORY DIAGNOSTICS MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 76
RESPIRATORY DIAGNOSTICS MARKET FOR PNEUMONIA, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 77
RESPIRATORY DIAGNOSTICS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 78
RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 79
SYNDROMIC DIAGNOSIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 80
ETIOLOGICAL DIAGNOSIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 81
PROGNOSIS DIAGNOSIS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 82
RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 83
RESPIRATORY DIAGNOSTICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 84
RESPIRATORY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 85
RESPIRATORY DIAGNOSTICS MARKET FOR LONG-TERM CARE & SPECIALTY CENTERS, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 86
RESPIRATORY DIAGNOSTICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 87
RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 89
NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 90
NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 91
NORTH AMERICA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 92
NORTH AMERICA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 93
NORTH AMERICA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 94
NORTH AMERICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 95
NORTH AMERICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 96
NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 97
NORTH AMERICA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 98
NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 99
NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 100
US: KEY MACROINDICATORS
TABLE 101
US: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 102
US: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 103
US: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 104
US: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 105
US: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 106
US: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 107
US: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 108
US: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 109
US: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 110
US: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 111
US: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 112
CANADA: KEY MACROINDICATORS
TABLE 113
CANADA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 114
CANADA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 115
CANADA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 116
CANADA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 117
CANADA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 118
CANADA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 119
CANADA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 120
CANADA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 121
CANADA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 122
CANADA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 123
CANADA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 124
EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 125
EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 126
EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 127
EUROPE: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 128
EUROPE: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 129
EUROPE: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 130
EUROPE: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 131
EUROPE: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 132
EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 133
EUROPE: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 134
EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 135
EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 136
GERMANY: KEY MACROINDICATORS
TABLE 137
GERMANY: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 138
GERMANY: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 139
GERMANY: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 140
GERMANY: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 141
GERMANY: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 142
GERMANY: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 143
GERMANY: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 144
GERMANY: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 145
GERMANY: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 146
GERMANY: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 147
GERMANY: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 148
UK: KEY MACROINDICATORS
TABLE 149
UK: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 150
UK: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 151
UK: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 152
UK: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 153
UK: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 154
UK: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 155
UK: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 156
UK: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 157
UK: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 158
UK: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 159
UK: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 160
FRANCE: KEY MACROINDICATORS
TABLE 161
FRANCE: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 162
FRANCE: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 163
FRANCE: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 164
FRANCE: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 165
FRANCE: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 166
FRANCE: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 167
FRANCE: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 168
FRANCE: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 169
FRANCE: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 170
FRANCE: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 171
FRANCE: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 172
ITALY: KEY MACROINDICATORS
TABLE 173
ITALY: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 174
ITALY: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 175
ITALY: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 176
ITALY: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 177
ITALY: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 178
ITALY: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 179
ITALY: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 180
ITALY: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 181
ITALY: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 182
ITALY: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 183
ITALY: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 184
SPAIN: KEY MACROINDICATORS
TABLE 185
SPAIN: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 186
SPAIN: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 187
SPAIN: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 188
SPAIN: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 189
SPAIN: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 190
SPAIN: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 191
SPAIN: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 192
SPAIN: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 193
SPAIN: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 194
SPAIN: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 195
SPAIN: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 196
REST OF EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 197
REST OF EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 198
REST OF EUROPE: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 199
REST OF EUROPE: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 200
REST OF EUROPE: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 201
REST OF EUROPE: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 202
REST OF EUROPE: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 203
REST OF EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 204
REST OF EUROPE: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 205
REST OF EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 206
REST OF EUROPE: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 207
ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 208
ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 209
ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 210
ASIA PACIFIC: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 211
ASIA PACIFIC: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 212
ASIA PACIFIC: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 213
ASIA PACIFIC: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 214
ASIA PACIFIC: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 215
ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 216
ASIA PACIFIC: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 217
ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 218
ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 219
JAPAN: KEY MACROINDICATORS
TABLE 220
JAPAN: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 221
JAPAN: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 222
JAPAN: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 223
JAPAN: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 224
JAPAN: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 225
JAPAN: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 226
JAPAN: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 227
JAPAN: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 228
JAPAN: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 229
JAPAN: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 230
JAPAN: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 231
CHINA: KEY MACROINDICATORS
TABLE 232
CHINA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 233
CHINA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 234
CHINA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 235
CHINA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 236
CHINA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 237
CHINA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 238
CHINA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 239
CHINA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 240
CHINA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 241
CHINA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 242
CHINA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 243
INDIA: KEY MACROINDICATORS
TABLE 244
INDIA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 245
INDIA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 246
INDIA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 247
INDIA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 248
INDIA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 249
INDIA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 250
INDIA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 251
INDIA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 252
INDIA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 253
INDIA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 254
INDIA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 255
AUSTRALIA: KEY MACROINDICATORS
TABLE 256
AUSTRALIA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 257
AUSTRALIA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 258
AUSTRALIA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 259
AUSTRALIA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 260
AUSTRALIA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 261
AUSTRALIA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 262
AUSTRALIA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 263
AUSTRALIA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 264
AUSTRALIA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 265
AUSTRALIA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 266
AUSTRALIA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 267
SOUTH KOREA: KEY MACROINDICATORS
TABLE 268
SOUTH KOREA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 269
SOUTH KOREA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 270
SOUTH KOREA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 271
SOUTH KOREA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 272
SOUTH KOREA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 273
SOUTH KOREA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 274
SOUTH KOREA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 275
SOUTH KOREA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 276
SOUTH KOREA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 277
SOUTH KOREA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 278
SOUTH KOREA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 279
REST OF ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 280
REST OF ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 281
REST OF ASIA PACIFIC: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 282
REST OF ASIA PACIFIC: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 283
REST OF ASIA PACIFIC: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 284
REST OF ASIA PACIFIC: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 285
REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 286
REST OF ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 287
REST OF ASIA PACIFIC: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 288
REST OF ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 289
REST OF ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 290
LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 291
LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 292
LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 293
LATIN AMERICA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 294
LATIN AMERICA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 295
LATIN AMERICA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 296
LATIN AMERICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 297
LATIN AMERICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 298
LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 299
LATIN AMERICA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 300
LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 301
LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 302
BRAZIL: KEY MACROINDICATORS
TABLE 303
BRAZIL: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 304
BRAZIL: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 305
BRAZIL: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 306
BRAZIL: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 307
BRAZIL: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 308
BRAZIL: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 309
BRAZIL: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 310
BRAZIL: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 311
BRAZIL: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 312
BRAZIL: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 313
BRAZIL: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 314
MEXICO: KEY MACROINDICATORS
TABLE 315
MEXICO: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 316
MEXICO: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 317
MEXICO: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 318
MEXICO: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 319
MEXICO: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 320
MEXICO: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 321
MEXICO: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 322
MEXICO: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 323
MEXICO: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 324
MEXICO: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 325
MEXICO: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 326
REST OF LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 327
REST OF LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 328
REST OF LATIN AMERICA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 329
REST OF LATIN AMERICA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 330
REST OF LATIN AMERICA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 331
REST OF LATIN AMERICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 332
REST OF LATIN AMERICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 333
REST OF LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 334
REST OF LATIN AMERICA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 335
REST OF LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 336
REST OF LATIN AMERICA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 337
MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 338
MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 339
MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 340
MIDDLE EAST & AFRICA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 341
MIDDLE EAST & AFRICA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 342
MIDDLE EAST & AFRICA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 343
MIDDLE EAST & AFRICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 344
MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 345
MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 346
MIDDLE EAST & AFRICA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 347
MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 348
MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 349
GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 350
GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 351
GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 352
GCC COUNTRIES: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 353
GCC COUNTRIES: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 354
GCC COUNTRIES: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 355
GCC COUNTRIES: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 356
GCC COUNTRIES: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 357
GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 358
GCC COUNTRIES: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 359
GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 360
GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 361
KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
TABLE 362
KINGDOM OF SAUDI ARABIA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 363
KINGDOM OF SAUDI ARABIA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 364
KINGDOM OF SAUDI ARABIA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 365
KINGDOM OF SAUDI ARABIA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 366
KINGDOM OF SAUDI ARABIA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 367
KINGDOM OF SAUDI ARABIA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 368
KINGDOM OF SAUDI ARABIA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 369
KINGDOM OF SAUDI ARABIA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 370
KINGDOM OF SAUDI ARABIA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 371
KINGDOM OF SAUDI ARABIA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 372
KINGDOM OF SAUDI ARABIA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 373
UNITED ARAB EMIRATES: KEY MACROINDICATORS
TABLE 374
UNITED ARAB EMIRATES: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 375
UNITED ARAB EMIRATES: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 376
UNITED ARAB EMIRATES: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 377
UNITED ARAB EMIRATES: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 378
UNITED ARAB EMIRATES: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 379
UNITED ARAB EMIRATES: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 380
UNITED ARAB EMIRATES: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 381
UNITED ARAB EMIRATES: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 382
UNITED ARAB EMIRATES: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 383
UNITED ARAB EMIRATES: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 384
UNITED ARAB EMIRATES: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 385
OTHER GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 386
OTHER GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 387
OTHER GCC COUNTRIES: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 388
OTHER GCC COUNTRIES: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 389
OTHER GCC COUNTRIES: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 390
OTHER GCC COUNTRIES: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 391
OTHER GCC COUNTRIES: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 392
OTHER GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 393
OTHER GCC COUNTRIES: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 394
OTHER GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 395
OTHER GCC COUNTRIES: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 396
REST OF MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2030 (USD MILLION)
TABLE 397
REST OF MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 398
REST OF MIDDLE EAST & AFRICA: MECHANICAL TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 399
REST OF MIDDLE EAST & AFRICA: PULMONARY FUNCTION TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 400
REST OF MIDDLE EAST & AFRICA: IMAGING TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 401
REST OF MIDDLE EAST & AFRICA: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 402
REST OF MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTIC TESTS MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 403
REST OF MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2022–2030 (USD MILLION)
TABLE 404
REST OF MIDDLE EAST & AFRICA: LUNG CANCER MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 405
REST OF MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2022–2030 (USD MILLION)
TABLE 406
REST OF MIDDLE EAST & AFRICA: RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 407
RESPIRATORY DIAGNOSTIC MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2021–DECEMBER 2024
TABLE 408
RESPIRATORY DIAGNOSTICS MARKET: DEGREE OF COMPETITION, 2023
TABLE 409
RESPIRATORY DIAGNOSTICS MARKET: REGIONAL FOOTPRINT
TABLE 410
RESPIRATORY DIAGNOSTICS MARKET: PRODUCT & SERVICE FOOTPRINT
TABLE 411
RESPIRATORY DIAGNOSTICS MARKET: TEST TYPE FOOTPRINT
TABLE 412
RESPIRATORY DIAGNOSTICS MARKET: DISEASE TYPE FOOTPRINT
TABLE 413
RESPIRATORY DIAGNOSTICS MARKET: END-USER FOOTPRINT
TABLE 414
RESPIRATORY DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 415
RESPIRATORY DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 416
RESPIRATORY DIAGNOSTICS MARKET: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 417
RESPIRATORY DIAGNOSTICS MARKET: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 418
RESPIRATORY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 419
RESPIRATORY DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
TABLE 420
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 421
KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED
TABLE 422
KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 423
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 424
KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 425
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 426
BECTON, DICKINSON AND COMPANY: PRODUCTS & SERVICES OFFERED
TABLE 427
BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 428
BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 429
ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 430
ABBOTT LABORATORIES: PRODUCTS & SERVICES OFFERED
TABLE 431
ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 432
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 433
THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
TABLE 434
THERMO FISHER SCIENTIFIC INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 435
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 436
GE HEALTHCARE TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 437
GE HEALTHCARE TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 438
GE HEALTHCARE TECHNOLOGIES, INC.: PRODUCT & SERVICE LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 439
GE HEALTHCARE TECHNOLOGIES, INC.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 440
GE HEALTHCARE TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
TABLE 441
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 442
BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 443
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 444
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 445
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 446
BIOMÉRIEUX: PRODUCTS & SERVICES OFFERED
TABLE 447
BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 448
BIOMÉRIEUX: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 449
REVVITY, INC.: COMPANY OVERVIEW
TABLE 450
REVVITY, INC.: PRODUCTS & SERVICES OFFERED
TABLE 451
REVVITY, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 452
REVVITY, INC.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 453
SEEGENE INC.: COMPANY OVERVIEW
TABLE 454
SEEGENE INC.: PRODUCTS & SERVICES OFFERED
TABLE 455
SEEGENE INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 456
SEEGENE INC.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 457
SEEGENE INC.: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 458
SEEGENE INC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
TABLE 459
NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
TABLE 460
NIHON KOHDEN CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 461
VITALOGRAPH: COMPANY OVERVIEW
TABLE 462
VITALOGRAPH: PRODUCTS & SERVICES OFFERED
TABLE 463
VITALOGRAPH: PRODUCT & SERVICE LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
TABLE 464
VITALOGRAPH: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 465
SDI DIAGNOSTICS: COMPANY OVERVIEW
TABLE 466
SDI DIAGNOSTICS: PRODUCTS & SERVICES OFFERED
TABLE 467
RESMED INC.: COMPANY OVERVIEW
TABLE 468
RESMED INC.: PRODUCTS & SERVICES OFFERED
TABLE 469
RESMED INC.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 470
RESMED INC.: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 471
RESMED INC.: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
TABLE 472
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 473
SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED
TABLE 474
SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 475
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 476
SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021–DECEMBER 2024
TABLE 477
COSMED SRL: COMPANY OVERVIEW
TABLE 478
COSMED SRL: PRODUCTS & SERVICES OFFERED
TABLE 479
COSMED SRL: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 480
COSMED SRL: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 481
HOLOGIC, INC.: COMPANY OVERVIEW
TABLE 482
HOLOGIC, INC.: PRODUCTS & SERVICES OFFERED
TABLE 483
HOLOGIC, INC.: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 484
HOLOGIC, INC.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 485
QIAGEN N.V.: COMPANY OVERVIEW
TABLE 486
QIAGEN N.V.: PRODUCTS & SERVICES OFFERED
TABLE 487
QIAGEN N.V.: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
TABLE 488
QIAGEN N.V.: DEALS, JANUARY 2021–DECEMBER 2024
TABLE 489
QIAGEN N.V.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
FIGURE 1
RESPIRATORY DIAGNOSTICS MARKET: MARKET & REGIONAL SPREAD
FIGURE 2
RESPIRATORY DIAGNOSTICS MARKET: YEARS CONSIDERED
FIGURE 4
RESPIRATORY DIAGNOSTICS MARKET: KEY PRIMARY SOURCES
FIGURE 5
RESPIRATORY DIAGNOSTICS MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 6
RESPIRATORY DIAGNOSTICS MARKET: KEY INDUSTRY INSIGHTS
FIGURE 7
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 9
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 10
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 11
REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. (2023)
FIGURE 12
SUPPLY-SIDE ANALYSIS: RESPIRATORY DIAGNOSTICS MARKET (2023)
FIGURE 13
RESPIRATORY DIAGNOSTICS MARKET: TOP-DOWN APPROACH
FIGURE 14
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 16
RESPIRATORY DIAGNOSTICS MARKET: DATA TRIANGULATION METHODOLOGY
FIGURE 17
RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2030 (USD MILLION)
FIGURE 18
RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE, 2024 VS. 2030 (USD MILLION)
FIGURE 19
RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024 VS. 2030 (USD MILLION)
FIGURE 20
RESPIRATORY DIAGNOSTICS MARKET, BY DIAGNOSIS TYPE, 2024 VS. 2030 (USD MILLION)
FIGURE 21
RESPIRATORY DIAGNOSTICS MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
FIGURE 22
GEOGRAPHIC SNAPSHOT OF RESPIRATORY DIAGNOSTICS MARKET
FIGURE 23
RISING PREVALENCE OF RESPIRATORY DISEASES TO PROPEL MARKET
FIGURE 24
INSTRUMENTS & DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA (2023)
FIGURE 25
ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 26
INDIA TO GROW AT HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 27
RESPIRATORY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 28
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DALY FOR INDIVIDUALS IN AUSTRALIA, BY AGE (2023)
FIGURE 29
GLOBAL GERIATRIC POPULATION, BY REGION
FIGURE 30
RESPIRATORY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31
NUMBER OF PATENTS PUBLISHED, JANUARY 2014–DECEMBER 2024
FIGURE 32
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RESPIRATORY DIAGNOSTICS DEVICES (JANUARY 2014– DECEMBER 2024)
FIGURE 33
TOP PATENT APPLICANTS, BY JURISDICTION, JANUARY 2014−DECEMBER 2024
FIGURE 34
AVERAGE SELLING PRICE OF SPIROMETERS, BY KEY PLAYER (2024)
FIGURE 35
AVERAGE SELLING PRICE OF PEAK FLOWMETERS, BY KEY PLAYER (2024)
FIGURE 36
RESPIRATORY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 37
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY DIAGNOSTIC DEVICES
FIGURE 38
KEY BUYING CRITERIA FOR RESPIRATORY DIAGNOSTIC DEVICES
FIGURE 39
RESPIRATORY DIAGNOSTICS MARKET: ADJACENT MARKETS
FIGURE 40
RESPIRATORY DIAGNOSTICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 41
RESPIRATORY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 42
RESPIRATORY DIAGNOSTICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 43
RESPIRATORY DIAGNOSTICS MARKET: NUMBER OF DEALS, 2020–2024
FIGURE 44
RESPIRATORY DIAGNOSTICS MARKET: IMPACT OF AI/GEN AI
FIGURE 45
RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT
FIGURE 46
NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT
FIGURE 47
ASIA PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT
FIGURE 48
RESPIRATORY DIAGNOSTICS MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019−2023
FIGURE 49
MARKET SHARE ANALYSIS OF KEY PLAYERS IN RESPIRATORY DIAGNOSTICS MARKET (2023)
FIGURE 50
RANKING OF KEY PLAYERS IN RESPIRATORY DIAGNOSTICS MARKET, 2023
FIGURE 51
RESPIRATORY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 52
RESPIRATORY DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 53
RESPIRATORY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 54
RESPIRATORY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 55
R&D EXPENDITURE OF KEY PLAYERS IN RESPIRATORY DIAGNOSTICS MARKET, 2022−2024
FIGURE 56
EV/EBITDA OF KEY VENDORS
FIGURE 57
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 58
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
FIGURE 59
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
FIGURE 60
ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
FIGURE 61
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 62
GE HEALTHCARE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 63
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 64
BIOMÉRIEUX: COMPANY SNAPSHOT (2023)
FIGURE 65
REVVITY, INC.: COMPANY SNAPSHOT (2023)
FIGURE 66
SEEGENE INC.: COMPANY SNAPSHOT (2023)
FIGURE 67
NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 68
RESMED INC.: COMPANY SNAPSHOT (2024)
FIGURE 69
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
FIGURE 70
HOLOGIC, INC.: COMPANY SNAPSHOT (2024)
FIGURE 71
QIAGEN N.V.: COMPANY SNAPSHOT (2023)
Growth opportunities and latent adjacency in Respiratory Diagnostics Market